Overview

“Understanding Healthcare for Multi-Country Field and Secondary Data Observational Studies”

Overview

In this era of evidence-based medicine, clinicians require a comprehensive range of well-designed studies to support health decisions and management. In recent years, data from observational studies have become an increasingly important source of evidence due to improvements in observational-study methods and advances in statistical analysis.

This webinar series is focused on moving toward a continuously learning health system and how evidence is applied to ensure and improve best care practices.

European Pharmaco-epidemiologists and clinicians experienced in Safety and Outcomes observational studies will make presentations and lead practice guidelines based on their experience with drugs and vaccines.

Attend any of this webinars to acquire practical knowledge and apply it to safety and outcomes observational studies in different therapeutic areas.

Besides 2 specific webinars focused on Field Studies and Database Studies, there are webinars for different countries: Italy, France, UK, Germany, Nordic countries, Spain, Japan, Taiwan, South Korea and China.

Register for an understanding of the healthcare system and how medicine is practiced:

  • Expert insights from European Pharmaco-epidemiologists and clinicians

Register to learn to design and plan successful safety and outcomes studies

  • First-hand case studies on how to increase the value of your studies

 

Who should attend

Professionals in European and non-European organisations involved in the conduct of observational studies in Europe:

Scientific leads, drug safety and clinical researchers and developers, statisticians & heath economist, biostatisticians, epidemiologists, health care informaticians, health care analytics, research funders, health products industry, clinicians, payers, and medical affairs staff and regulators.

 

Language

English

 

Programme

We have built this webinar series on the success of the 3-day course previously held at the Royal Society of Medicine, London over several years with leading national pharmacoepidemiologist.

Our keynote webinars focus on learning from national academic and regulatory experts practical knowledge to apply to your next field, secondary data or hybrid observational study for safety, HEOR/market access, drug development and marketing.

Topics of each country includes:

• Structure of healthcare
• Clinical practice patterns
• Data sources
• Strengths and limitations for observational studies
• How to overcome challenges for secondary data sources and field studies and use of innovative methodologies for different therapeutic areas, patient groups (e.g. pregnancy outcomes, children), drugs and vaccines.

For specific calendar, please refer to our section Calendar.

 

Registration

You may register interest online for one or several webinars by using the registration form.
Number of attendees is limited to permit adequate discussion and feedback during the presentation.

Reserve your seat!